These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37574157)

  • 1. Exploring the therapeutic potential of a nano micelle containing a carbon monoxide-releasing molecule for metabolic-associated fatty liver disease by modulating hypoxia-inducible factor-1α.
    Cui Y; Guo C; Xia Z; Xue Y; Song B; Hu W; He X; Liang S; Wei Y; Zhang C; Wang H; Xu D; Zhang S; Fang J
    Acta Biomater; 2023 Oct; 169():500-516. PubMed ID: 37574157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoformulation of a carbon monoxide releasing molecule protects against cyclosporin A-induced nephrotoxicity and renal fibrosis via the suppression of the NLRP3 inflammasome mediated TGF-β/Smad pathway.
    Xia Z; Zhang C; Guo C; Song B; Hu W; Cui Y; Xue Y; Xia M; Xu D; Zhang S; Fang J
    Acta Biomater; 2022 May; 144():42-53. PubMed ID: 35304324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-designed carbon monoxide donor SMA/CORM2 exhibits protective effect against acetaminophen induced liver injury through macrophage reprograming and promoting liver regeneration.
    Song B; Zhang C; Hu W; Guo C; Xia Z; Hu W; Qin M; Jiang W; Lv J; Xu D; Zhang S; Fang J
    J Control Release; 2021 Mar; 331():350-363. PubMed ID: 33482271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric nano-micelle of carbon monoxide donor SMA/CORM2 ameliorates acetaminophen-induced liver injury via suppressing HMGB1/TLR4 signaling pathway.
    Xue Y; Zhang D; Wei Y; Guo C; Song B; Cui Y; Zhang C; Xu D; Zhang S; Fang J
    Eur J Pharm Sci; 2023 May; 184():106413. PubMed ID: 36863618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-designed CO donor ameliorates bleomycin-induced pulmonary fibrosis via macrophage manipulation.
    Guo C; Zhang C; Xia Z; Song B; Hu W; Cui Y; Xue Y; Xia M; Xu D; Zhang S; Fang J
    J Control Release; 2022 Jan; 341():566-577. PubMed ID: 34864115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Styrene-maleic acid copolymer-encapsulated CORM2, a water-soluble carbon monoxide (CO) donor with a constant CO-releasing property, exhibits therapeutic potential for inflammatory bowel disease.
    Yin H; Fang J; Liao L; Nakamura H; Maeda H
    J Control Release; 2014 Aug; 187():14-21. PubMed ID: 24852097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon monoxide protects against hepatic steatosis in mice by inducing sestrin-2 via the PERK-eIF2α-ATF4 pathway.
    Kim HJ; Joe Y; Kim SK; Park SU; Park J; Chen Y; Kim J; Ryu J; Cho GJ; Surh YJ; Ryter SW; Kim UH; Chung HT
    Free Radic Biol Med; 2017 Sep; 110():81-91. PubMed ID: 28578014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-Specific Hypoxia-Inducible Factor-1α Contributes to Impaired Autophagic Flux in Nonalcoholic Steatohepatitis.
    Wang X; de Carvalho Ribeiro M; Iracheta-Vellve A; Lowe P; Ambade A; Satishchandran A; Bukong T; Catalano D; Kodys K; Szabo G
    Hepatology; 2019 Feb; 69(2):545-563. PubMed ID: 30102772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.
    Csak T; Bala S; Lippai D; Satishchandran A; Catalano D; Kodys K; Szabo G
    Liver Int; 2015 Feb; 35(2):532-41. PubMed ID: 25040043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury.
    Yang YY; Lee PC; Huang YT; Lee WP; Kuo YJ; Lee KC; Hsieh YC; Lee TY; Lin HC
    Clin Sci (Lond); 2014 Jan; 126(2):163-74. PubMed ID: 23875703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1α/NF-κB cascade regulation of ROS scavenging and macrophage repolarization.
    Li Y; Liang Q; Zhou L; Cao Y; Yang J; Li J; Liu J; Bi J; Liu Y
    Acta Biomater; 2022 Oct; 152():406-424. PubMed ID: 36055613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network pharmacology-based identification of significant pathway for protection of Yinhuang granule in a mice model of metabolic-associated fatty liver disease.
    Yan S; Zhang S; Du A; Miao H; Lu B; Huang Z; Ji L
    Phytomedicine; 2021 Oct; 91():153666. PubMed ID: 34339944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia inducible factor-1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway.
    Han J; He Y; Zhao H; Xu X
    J Cell Biochem; 2019 Sep; 120(9):14735-14744. PubMed ID: 31009107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver.
    Arai T; Tanaka M; Goda N
    Sci Rep; 2018 Sep; 8(1):14230. PubMed ID: 30242180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
    Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
    Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice.
    Liu X; Huang K; Niu Z; Mei D; Zhang B
    Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):144-153. PubMed ID: 30180301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PKM2 activator TEPP-46 attenuates MCD feeding-induced nonalcoholic steatohepatitis by inhibiting the activation of Kupffer cells.
    Yang SH; Wu H; Yi ZJ; Lai X
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4017-4026. PubMed ID: 34156680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation.
    Zhao P; Han SN; Arumugam S; Yousaf MN; Qin Y; Jiang JX; Torok NJ; Chen Y; Mankash MS; Liu J; Li J; Iwakiri Y; Ouyang X
    Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G387-G397. PubMed ID: 31411894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning.
    Chin BY; Jiang G; Wegiel B; Wang HJ; Macdonald T; Zhang XC; Gallo D; Cszimadia E; Bach FH; Lee PJ; Otterbein LE
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5109-14. PubMed ID: 17360382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 20(S)-Protopanaxatriol ameliorates MAFLD by inhibiting NLRP3 inflammasome.
    Lu B; Wang D; Xie D; Wu C; Sun M
    Eur J Pharmacol; 2023 Feb; 940():175468. PubMed ID: 36566009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.